Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies.
Tam CS, Dimopoulos M, Garcia-Sanz R, Trotman J, Opat S, Roberts AW, Owen R, Song Y, Xu W, Zhu J, Li J, Qiu L, D'Sa S, Jurczak W, Cull G, Marlton P, Gottlieb D, Munoz J, Phillips T, Du C, Ji M, Zhou L, Guo H, Zhu H, Chan WY, Cohen A, Novotny W, Huang J, Tedeschi A. Tam CS, et al. Among authors: ji m. Blood Adv. 2022 Feb 22;6(4):1296-1308. doi: 10.1182/bloodadvances.2021005621. Blood Adv. 2022. PMID: 34724705 Free PMC article.
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study.
Xu W, Yang S, Zhou K, Pan L, Li Z, Zhou J, Gao S, Zhou D, Hu J, Feng R, Huang H, Ji M, Guo H, Huang J, Novotny W, Feng S, Li J. Xu W, et al. Among authors: ji m. J Hematol Oncol. 2020 May 11;13(1):48. doi: 10.1186/s13045-020-00884-4. J Hematol Oncol. 2020. PMID: 32393328 Free PMC article. Clinical Trial.
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
Hillmen P, Eichhorst B, Brown JR, Lamanna N, O'Brien SM, Tam CS, Qiu L, Kazmierczak M, Zhou K, Šimkovič M, Mayer J, Gillespie-Twardy A, Shadman M, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Österborg A, Yimer HA, Salmi T, Ji M, Yecies J, Idoine A, Wu K, Huang J, Jurczak W. Hillmen P, et al. Among authors: ji m. J Clin Oncol. 2023 Feb 10;41(5):1035-1045. doi: 10.1200/JCO.22.00510. Epub 2022 Nov 17. J Clin Oncol. 2023. PMID: 36395435 Free PMC article. Clinical Trial.
Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis.
Xu W, Yang S, Zhou K, Pan L, Li Z, Gao S, Zhou D, Hu J, Feng R, Huang H, Wang T, Li D, Ji M, Guo H, Zhao X, Wu B, Yu Y, Wang Y, Huang J, Novotny W, Li J. Xu W, et al. Among authors: ji m. Leuk Lymphoma. 2023 Mar;64(3):712-716. doi: 10.1080/10428194.2022.2164692. Epub 2023 Feb 17. Leuk Lymphoma. 2023. PMID: 36799536 Free article. No abstract available.
Connection between oral health and chronic diseases.
Fu D, Shu X, Zhou G, Ji M, Liao G, Zou L. Fu D, et al. Among authors: ji m. MedComm (2020). 2025 Jan 14;6(1):e70052. doi: 10.1002/mco2.70052. eCollection 2025 Jan. MedComm (2020). 2025. PMID: 39811802 Free PMC article. Review.
Spatial transcriptomic characterization of a Carnegie stage 7 human embryo.
Cui L, Lin S, Yang X, Xie X, Wang X, He N, Yang J, Zhang X, Lu X, Yan X, Guo Y, Zhang B, Li R, Miao H, Ji M, Zhang R, Yu L, Xiao Z, Wei Y, Guo J. Cui L, et al. Among authors: ji m. Nat Cell Biol. 2025 Jan 10. doi: 10.1038/s41556-024-01597-3. Online ahead of print. Nat Cell Biol. 2025. PMID: 39794460
Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma.
Zeng Y, Luo CL, Lin GW, Li F, Bai X, Ko JM, Xiong L, Liu Y, He S, Jiang JX, Yan WX, Ong EHW, Li Z, Zhou YQ, Zhou YH, Xu AY, Liu SQ, Guo YM, Chen JR, Cheng XX, Cao YL, Yu X, Wu B, Wei PP, Ruan ZH, Chen QY, Tang LQ, McKay JD, Jia WH, Mai HQ, Lim ST, Liu JJ, Lin DX, Khor CC, Chua MLK, Ji M, Lung ML, Zeng YX, Bei JX. Zeng Y, et al. Among authors: ji m. J Clin Invest. 2025 Jan 2;135(1):e182768. doi: 10.1172/JCI182768. J Clin Invest. 2025. PMID: 39744943 Free PMC article.
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial.
Zhong J, Fei K, Wu L, Li B, Wang Z, Cheng Y, Li X, Wang X, Han L, Wu X, Fan Y, Yu Y, Lv D, Shi J, Huang J, Zhou S, Han B, Sun G, Guo Q, Ji Y, Zhu X, Hu S, Zhang W, Wang Q, Jia Y, Wang Z, Song Y, Wu J, Shi M, Li X, Han Z, Liu Y, Yu Z, Liu AW, Wang X, Zhou C, Zhong D, Miao L, Zhang Z, Zhao H, Yang J, Wang D, Wang Y, Li Q, Zhang X, Ji M, Yang Z, Cui J, Gao B, Wang B, Liu H, Nie L, He M, Jin S, Gu W, Shu Y, Zhou T, Feng J, Yang X, Huang C, Zhu B, Yao Y, Yao S, Yu J, Cai SL, Cai Y, Xu J, Zhuang W, Luo X, Duan J, Wang J. Zhong J, et al. Among authors: ji y, ji m. Signal Transduct Target Ther. 2024 Dec 24;9(1):369. doi: 10.1038/s41392-024-02087-6. Signal Transduct Target Ther. 2024. PMID: 39715755 Free PMC article. Clinical Trial.
Simulation and assimilation of the digital human brain.
Lu W, Du X, Wang J, Zeng L, Ye L, Xiang S, Zheng Q, Zhang J, Xu N, Feng J; DTB Consortium. Lu W, et al. Nat Comput Sci. 2024 Dec;4(12):890-898. doi: 10.1038/s43588-024-00731-3. Epub 2024 Dec 19. Nat Comput Sci. 2024. PMID: 39702784
Fast synthesis of DNA origami single crystals at room temperature.
Yu Y, Ji M, Wang Y, Yan X, Dai L, Ma N, Zhou Z, Xing H, Tian Y. Yu Y, et al. Among authors: ji m. Chem Sci. 2024 Dec 4;16(2):793-801. doi: 10.1039/d4sc07267g. eCollection 2025 Jan 2. Chem Sci. 2024. PMID: 39640022 Free PMC article.
A plain language summary of results from the CHOICE-01 trial of toripalimab plus chemotherapy for advanced non-small cell lung cancer (NSCLC).
Wang Z, Wu L, Li B, Cheng Y, Li X, Wang X, Han L, Wu X, Fan Y, Yu Y, Lv D, Shi J, Huang J, Zhou S, Han B, Sun G, Guo Q, Ji Y, Zhu X, Hu S, Zhang W, Wang Q, Jia Y, Wang Z, Song Y, Wu J, Shi M, Li X, Han Z, Liu Y, Yu Z, Liu AW, Wang X, Zhou C, Zhong D, Miao L, Zhang Z, Zhao H, Yang J, Wang D, Wang Y, Li Q, Zhang X, Ji M, Yang Z, Cui J, Gao B, Wang B, Liu H, Nie L, He M, Jin S, Gu W, Shu Y, Zhou T, Feng J, Yang X, Huang C, Zhu B, Yao Y, Tang X, Yu J, Maher E, Feng H, Yao S, Keegan P, Wang J. Wang Z, et al. Among authors: ji y, ji m. Future Oncol. 2024 Dec 4:1-8. doi: 10.1080/14796694.2024.2426951. Online ahead of print. Future Oncol. 2024. PMID: 39628302 Free article.
Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids.
Liang Y, Yang R, Wei Y, Huang B, Chen Y, Zhang X, Yao J, Wang G, Mao H, Shi H, Yang Q, Tang J, Ji M, Hua K, Yao S. Liang Y, et al. Among authors: ji m. Gynecol Endocrinol. 2024 Dec;40(1):2427190. doi: 10.1080/09513590.2024.2427190. Epub 2024 Dec 3. Gynecol Endocrinol. 2024. PMID: 39624028 Free article. Clinical Trial.
A large-scale population-based study reveals that gp42-IgG antibody is protective against Epstein-Barr virus-associated nasopharyngeal carcinoma.
Kong XW, Bu GL, Chen H, Huang YH, Liu Z, Kang YF, Li YC, Yu X, Wu BH, Li ZQ, Chen XC, Xie SH, Lin DF, Li T, Yan SM, Han RK, Huang N, Wang QY, Li Y, Zhang A, Zhong Q, Huang XM, Ye W, Ji MF, Cai YL, Cao SM, Zeng MS. Kong XW, et al. J Clin Invest. 2024 Nov 26:e180216. doi: 10.1172/JCI180216. Online ahead of print. J Clin Invest. 2024. PMID: 39589824 Free article.
Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9-14-year-old and 18-26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trial.
Li J, Shi LW, Li K, Huang LR, Li JB, Dong YL, Li W, Ji M, Yang Q, Zhou LY, Yuan L, Yan XM, Chen JJ, Jiang ZW, Qi YY, Li RC, Li YP, Xia JL, Yu BW, Mo ZJ, Li CG. Li J, et al. Among authors: ji m. Vaccine. 2023 Oct 26;41(48):7212-9. doi: 10.1016/j.vaccine.2023.10.041. Online ahead of print. Vaccine. 2023. PMID: 39492306 Free PMC article.
3,512 results